Sponsor or institution
Clinical trials and research at Kyushu University
As of November 12, 2026, Find a Trial lists 5 clinical trials run by Kyushu University that are recruiting, in Japan. By phase: Phase 1 (2), Phase 1/2 (2), Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 1Country
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Pitavastatin in PLGA Nanoparticles for Retinitis Pigmentosa safety test | Phase 1 | Fukuoka | Recruiting | Aug 19, 2026 |
| Sivelestat added to standard steroid therapy during an NMOSD attack | Phase 1/2 | Fukuoka | Recruiting | Jul 31, 2026 |
| Adding sotatercept to usual therapy for adults with Eisenmenger syndrome or unrepaired shunt-related pulmonary arterial hypertension | Phase 4 | Fukuoka, Not Required For This Country and 9 other locations | Recruiting | Jan 21, 2026 |
| Testing GAIA-102 for difficult-to-treat pediatric cancers | Phase 1 | Fukuoka, Fukuoka | Recruiting | Nov 8, 2022 |
| Treatment for advanced gastrointestinal cancer with malignant ascites | Phase 1/2 | Fukuoka, Fukuoka | Recruiting | Jun 30, 2022 |
All recruiting trials (5)
-
Pitavastatin in PLGA Nanoparticles for Retinitis Pigmentosa safety test
This Phase 1 study tests whether an intravenous pitavastatin nanoparticle formulation is safe for adults with retinitis pigmentosa.
-
Sivelestat added to standard steroid therapy during an NMOSD attack
This trial tests whether giving sivelestat in addition to standard steroid treatment is safe and helps people with an acute NMOSD attack.
-
Adding sotatercept to usual therapy for adults with Eisenmenger syndrome or unrepaired shunt-related pulmonary arterial hypertension
This study will test whether giving sotatercept in addition to standard PAH medicines helps adults with Eisenmenger syndrome or unrepaired shunt-associated pulmonary arterial hypertension that has not improved enough on vasodilators.
-
Testing GAIA-102 for difficult-to-treat pediatric cancers
This study is testing a new treatment called GAIA-102 for children with tough-to-treat cancers to see if it’s safe and how much of it they should get.
-
Treatment for advanced gastrointestinal cancer with malignant ascites
This study is testing a new treatment called GAIA-102, alone and with pembrolizumab, to see if it helps people with advanced gastrointestinal cancer and fluid buildup in the abdomen feel better.
Quick answers
How many clinical trials run by Kyushu University are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in Japan. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2, Phase 1/2: 2, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.